nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—Pain—Prednisolone—rheumatoid arthritis	0.00033	0.000428	CcSEcCtD
Duloxetine—Haemorrhage—Methotrexate—rheumatoid arthritis	0.00033	0.000428	CcSEcCtD
Duloxetine—Hepatitis—Methotrexate—rheumatoid arthritis	0.00033	0.000428	CcSEcCtD
Duloxetine—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000328	0.000425	CcSEcCtD
Duloxetine—Pharyngitis—Methotrexate—rheumatoid arthritis	0.000327	0.000425	CcSEcCtD
Duloxetine—Nausea—Leflunomide—rheumatoid arthritis	0.000326	0.000424	CcSEcCtD
Duloxetine—Urinary tract disorder—Methotrexate—rheumatoid arthritis	0.000326	0.000423	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000325	0.000422	CcSEcCtD
Duloxetine—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000325	0.000422	CcSEcCtD
Duloxetine—Vision blurred—Prednisone—rheumatoid arthritis	0.000324	0.00042	CcSEcCtD
Duloxetine—Urethral disorder—Methotrexate—rheumatoid arthritis	0.000323	0.00042	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000323	0.00042	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000323	0.000419	CcSEcCtD
Duloxetine—Pain—Hydrocortisone—rheumatoid arthritis	0.000322	0.000418	CcSEcCtD
Duloxetine—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	0.000322	0.000418	CcSEcCtD
Duloxetine—Oedema—Betamethasone—rheumatoid arthritis	0.000322	0.000418	CcSEcCtD
Duloxetine—Anaphylactic shock—Betamethasone—rheumatoid arthritis	0.000322	0.000418	CcSEcCtD
Duloxetine—Oedema—Dexamethasone—rheumatoid arthritis	0.000322	0.000418	CcSEcCtD
Duloxetine—Insomnia—Triamcinolone—rheumatoid arthritis	0.000321	0.000417	CcSEcCtD
Duloxetine—Insomnia—Methylprednisolone—rheumatoid arthritis	0.00032	0.000416	CcSEcCtD
Duloxetine—Infection—Betamethasone—rheumatoid arthritis	0.00032	0.000415	CcSEcCtD
Duloxetine—Infection—Dexamethasone—rheumatoid arthritis	0.00032	0.000415	CcSEcCtD
Duloxetine—Ill-defined disorder—Prednisone—rheumatoid arthritis	0.000319	0.000414	CcSEcCtD
Duloxetine—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.000319	0.000414	CcSEcCtD
Duloxetine—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.000318	0.000413	CcSEcCtD
Duloxetine—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.000318	0.000413	CcSEcCtD
Duloxetine—Visual impairment—Methotrexate—rheumatoid arthritis	0.000318	0.000413	CcSEcCtD
Duloxetine—Anaemia—Prednisone—rheumatoid arthritis	0.000318	0.000412	CcSEcCtD
Duloxetine—Shock—Dexamethasone—rheumatoid arthritis	0.000317	0.000411	CcSEcCtD
Duloxetine—Shock—Betamethasone—rheumatoid arthritis	0.000317	0.000411	CcSEcCtD
Duloxetine—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000316	0.00041	CcSEcCtD
Duloxetine—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000316	0.00041	CcSEcCtD
Duloxetine—Agitation—Prednisone—rheumatoid arthritis	0.000316	0.00041	CcSEcCtD
Duloxetine—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	0.000315	0.000409	CcSEcCtD
Duloxetine—Thrombocytopenia—Betamethasone—rheumatoid arthritis	0.000315	0.000409	CcSEcCtD
Duloxetine—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000314	0.000408	CcSEcCtD
Duloxetine—Tachycardia—Betamethasone—rheumatoid arthritis	0.000314	0.000408	CcSEcCtD
Duloxetine—Angioedema—Prednisone—rheumatoid arthritis	0.000314	0.000408	CcSEcCtD
Duloxetine—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.000312	0.000406	CcSEcCtD
Duloxetine—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.000312	0.000406	CcSEcCtD
Duloxetine—Erythema multiforme—Methotrexate—rheumatoid arthritis	0.000312	0.000405	CcSEcCtD
Duloxetine—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.000312	0.000405	CcSEcCtD
Duloxetine—Hyperhidrosis—Betamethasone—rheumatoid arthritis	0.000311	0.000404	CcSEcCtD
Duloxetine—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	0.000311	0.000404	CcSEcCtD
Duloxetine—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.000311	0.000403	CcSEcCtD
Duloxetine—Malaise—Prednisone—rheumatoid arthritis	0.00031	0.000402	CcSEcCtD
Duloxetine—Vertigo—Prednisone—rheumatoid arthritis	0.000309	0.000401	CcSEcCtD
Duloxetine—Eye disorder—Methotrexate—rheumatoid arthritis	0.000308	0.0004	CcSEcCtD
Duloxetine—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000308	0.0004	CcSEcCtD
Duloxetine—Syncope—Prednisone—rheumatoid arthritis	0.000308	0.0004	CcSEcCtD
Duloxetine—Tinnitus—Methotrexate—rheumatoid arthritis	0.000308	0.000399	CcSEcCtD
Duloxetine—Anorexia—Dexamethasone—rheumatoid arthritis	0.000307	0.000399	CcSEcCtD
Duloxetine—Anorexia—Betamethasone—rheumatoid arthritis	0.000307	0.000399	CcSEcCtD
Duloxetine—Urticaria—Prednisolone—rheumatoid arthritis	0.000307	0.000398	CcSEcCtD
Duloxetine—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.000306	0.000398	CcSEcCtD
Duloxetine—Fatigue—Triamcinolone—rheumatoid arthritis	0.000306	0.000397	CcSEcCtD
Duloxetine—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000305	0.000396	CcSEcCtD
Duloxetine—Asthenia—Cyclosporine—rheumatoid arthritis	0.000304	0.000395	CcSEcCtD
Duloxetine—Pain—Triamcinolone—rheumatoid arthritis	0.000303	0.000394	CcSEcCtD
Duloxetine—Loss of consciousness—Prednisone—rheumatoid arthritis	0.000302	0.000392	CcSEcCtD
Duloxetine—Pruritus—Cyclosporine—rheumatoid arthritis	0.0003	0.00039	CcSEcCtD
Duloxetine—Urticaria—Hydrocortisone—rheumatoid arthritis	0.000299	0.000389	CcSEcCtD
Duloxetine—Angiopathy—Methotrexate—rheumatoid arthritis	0.000299	0.000389	CcSEcCtD
Duloxetine—Immune system disorder—Methotrexate—rheumatoid arthritis	0.000298	0.000387	CcSEcCtD
Duloxetine—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000298	0.000387	CcSEcCtD
Duloxetine—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000298	0.000387	CcSEcCtD
Duloxetine—Convulsion—Prednisone—rheumatoid arthritis	0.000298	0.000387	CcSEcCtD
Duloxetine—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.000297	0.000386	CcSEcCtD
Duloxetine—Hypertension—Prednisone—rheumatoid arthritis	0.000297	0.000385	CcSEcCtD
Duloxetine—Chills—Methotrexate—rheumatoid arthritis	0.000296	0.000384	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000293	0.000381	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000293	0.000381	CcSEcCtD
Duloxetine—Arthralgia—Prednisone—rheumatoid arthritis	0.000292	0.00038	CcSEcCtD
Duloxetine—Myalgia—Prednisone—rheumatoid arthritis	0.000292	0.00038	CcSEcCtD
Duloxetine—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000292	0.00038	CcSEcCtD
Duloxetine—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.000292	0.000379	CcSEcCtD
Duloxetine—Anxiety—Prednisone—rheumatoid arthritis	0.000291	0.000379	CcSEcCtD
Duloxetine—Alopecia—Methotrexate—rheumatoid arthritis	0.000291	0.000378	CcSEcCtD
Duloxetine—Insomnia—Betamethasone—rheumatoid arthritis	0.000291	0.000378	CcSEcCtD
Duloxetine—Insomnia—Dexamethasone—rheumatoid arthritis	0.000291	0.000378	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.00029	0.000377	CcSEcCtD
Duloxetine—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.00029	0.000377	CcSEcCtD
Duloxetine—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000289	0.000376	CcSEcCtD
Duloxetine—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.000289	0.000375	CcSEcCtD
Duloxetine—Paraesthesia—Betamethasone—rheumatoid arthritis	0.000289	0.000375	CcSEcCtD
Duloxetine—Discomfort—Prednisone—rheumatoid arthritis	0.000289	0.000375	CcSEcCtD
Duloxetine—Mental disorder—Methotrexate—rheumatoid arthritis	0.000289	0.000375	CcSEcCtD
Duloxetine—Erythema—Methotrexate—rheumatoid arthritis	0.000287	0.000373	CcSEcCtD
Duloxetine—Malnutrition—Methotrexate—rheumatoid arthritis	0.000287	0.000373	CcSEcCtD
Duloxetine—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000284	0.000369	CcSEcCtD
Duloxetine—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.000283	0.000368	CcSEcCtD
Duloxetine—Dyspepsia—Betamethasone—rheumatoid arthritis	0.000283	0.000368	CcSEcCtD
Duloxetine—Urticaria—Triamcinolone—rheumatoid arthritis	0.000282	0.000366	CcSEcCtD
Duloxetine—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000281	0.000365	CcSEcCtD
Duloxetine—Dysgeusia—Methotrexate—rheumatoid arthritis	0.000281	0.000365	CcSEcCtD
Duloxetine—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.00028	0.000364	CcSEcCtD
Duloxetine—Dizziness—Cyclosporine—rheumatoid arthritis	0.00028	0.000364	CcSEcCtD
Duloxetine—Anaphylactic shock—Prednisone—rheumatoid arthritis	0.00028	0.000364	CcSEcCtD
Duloxetine—Oedema—Prednisone—rheumatoid arthritis	0.00028	0.000364	CcSEcCtD
Duloxetine—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.00028	0.000363	CcSEcCtD
Duloxetine—Decreased appetite—Betamethasone—rheumatoid arthritis	0.00028	0.000363	CcSEcCtD
Duloxetine—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.00028	0.000363	CcSEcCtD
Duloxetine—Infection—Prednisone—rheumatoid arthritis	0.000279	0.000362	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000278	0.000361	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000278	0.000361	CcSEcCtD
Duloxetine—Back pain—Methotrexate—rheumatoid arthritis	0.000278	0.000361	CcSEcCtD
Duloxetine—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000278	0.000361	CcSEcCtD
Duloxetine—Fatigue—Dexamethasone—rheumatoid arthritis	0.000278	0.00036	CcSEcCtD
Duloxetine—Fatigue—Betamethasone—rheumatoid arthritis	0.000278	0.00036	CcSEcCtD
Duloxetine—Shock—Prednisone—rheumatoid arthritis	0.000276	0.000358	CcSEcCtD
Duloxetine—Pain—Betamethasone—rheumatoid arthritis	0.000275	0.000358	CcSEcCtD
Duloxetine—Pain—Dexamethasone—rheumatoid arthritis	0.000275	0.000358	CcSEcCtD
Duloxetine—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000275	0.000357	CcSEcCtD
Duloxetine—Tachycardia—Prednisone—rheumatoid arthritis	0.000274	0.000355	CcSEcCtD
Duloxetine—Skin disorder—Prednisone—rheumatoid arthritis	0.000272	0.000354	CcSEcCtD
Duloxetine—Hyperhidrosis—Prednisone—rheumatoid arthritis	0.000271	0.000352	CcSEcCtD
Duloxetine—Vision blurred—Methotrexate—rheumatoid arthritis	0.000271	0.000351	CcSEcCtD
Duloxetine—Asthenia—Hydrocortisone—rheumatoid arthritis	0.00027	0.000351	CcSEcCtD
Duloxetine—Vomiting—Cyclosporine—rheumatoid arthritis	0.00027	0.00035	CcSEcCtD
Duloxetine—Rash—Cyclosporine—rheumatoid arthritis	0.000267	0.000347	CcSEcCtD
Duloxetine—Anorexia—Prednisone—rheumatoid arthritis	0.000267	0.000347	CcSEcCtD
Duloxetine—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000267	0.000347	CcSEcCtD
Duloxetine—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000267	0.000346	CcSEcCtD
Duloxetine—Ill-defined disorder—Methotrexate—rheumatoid arthritis	0.000266	0.000346	CcSEcCtD
Duloxetine—Headache—Cyclosporine—rheumatoid arthritis	0.000266	0.000345	CcSEcCtD
Duloxetine—Anaemia—Methotrexate—rheumatoid arthritis	0.000265	0.000345	CcSEcCtD
Duloxetine—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.000265	0.000345	CcSEcCtD
Duloxetine—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.000265	0.000345	CcSEcCtD
Duloxetine—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000263	0.000342	CcSEcCtD
Duloxetine—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000263	0.000342	CcSEcCtD
Duloxetine—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000261	0.000339	CcSEcCtD
Duloxetine—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000261	0.000339	CcSEcCtD
Duloxetine—Malaise—Methotrexate—rheumatoid arthritis	0.000259	0.000336	CcSEcCtD
Duloxetine—Vertigo—Methotrexate—rheumatoid arthritis	0.000258	0.000335	CcSEcCtD
Duloxetine—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.000258	0.000335	CcSEcCtD
Duloxetine—Leukopenia—Methotrexate—rheumatoid arthritis	0.000257	0.000334	CcSEcCtD
Duloxetine—Urticaria—Betamethasone—rheumatoid arthritis	0.000256	0.000332	CcSEcCtD
Duloxetine—Urticaria—Dexamethasone—rheumatoid arthritis	0.000256	0.000332	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	0.000255	0.000332	CcSEcCtD
Duloxetine—Dizziness—Prednisolone—rheumatoid arthritis	0.000255	0.000331	CcSEcCtD
Duloxetine—Asthenia—Triamcinolone—rheumatoid arthritis	0.000255	0.000331	CcSEcCtD
Duloxetine—Body temperature increased—Dexamethasone—rheumatoid arthritis	0.000255	0.000331	CcSEcCtD
Duloxetine—Abdominal pain—Betamethasone—rheumatoid arthritis	0.000255	0.000331	CcSEcCtD
Duloxetine—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.000255	0.000331	CcSEcCtD
Duloxetine—Body temperature increased—Betamethasone—rheumatoid arthritis	0.000255	0.000331	CcSEcCtD
Duloxetine—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000254	0.00033	CcSEcCtD
Duloxetine—Insomnia—Prednisone—rheumatoid arthritis	0.000254	0.000329	CcSEcCtD
Duloxetine—Nausea—Cyclosporine—rheumatoid arthritis	0.000252	0.000327	CcSEcCtD
Duloxetine—Paraesthesia—Prednisone—rheumatoid arthritis	0.000252	0.000327	CcSEcCtD
Duloxetine—Pruritus—Triamcinolone—rheumatoid arthritis	0.000251	0.000326	CcSEcCtD
Duloxetine—Cough—Methotrexate—rheumatoid arthritis	0.000251	0.000325	CcSEcCtD
Duloxetine—Pruritus—Methylprednisolone—rheumatoid arthritis	0.00025	0.000325	CcSEcCtD
Duloxetine—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000249	0.000324	CcSEcCtD
Duloxetine—Convulsion—Methotrexate—rheumatoid arthritis	0.000249	0.000323	CcSEcCtD
Duloxetine—Dyspepsia—Prednisone—rheumatoid arthritis	0.000247	0.000321	CcSEcCtD
Duloxetine—Chest pain—Methotrexate—rheumatoid arthritis	0.000244	0.000317	CcSEcCtD
Duloxetine—Arthralgia—Methotrexate—rheumatoid arthritis	0.000244	0.000317	CcSEcCtD
Duloxetine—Myalgia—Methotrexate—rheumatoid arthritis	0.000244	0.000317	CcSEcCtD
Duloxetine—Decreased appetite—Prednisone—rheumatoid arthritis	0.000244	0.000317	CcSEcCtD
Duloxetine—Rash—Prednisolone—rheumatoid arthritis	0.000243	0.000316	CcSEcCtD
Duloxetine—Dermatitis—Prednisolone—rheumatoid arthritis	0.000243	0.000316	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.000243	0.000315	CcSEcCtD
Duloxetine—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.000242	0.000315	CcSEcCtD
Duloxetine—Fatigue—Prednisone—rheumatoid arthritis	0.000242	0.000314	CcSEcCtD
Duloxetine—Headache—Prednisolone—rheumatoid arthritis	0.000242	0.000314	CcSEcCtD
Duloxetine—Discomfort—Methotrexate—rheumatoid arthritis	0.000241	0.000314	CcSEcCtD
Duloxetine—Constipation—Prednisone—rheumatoid arthritis	0.00024	0.000311	CcSEcCtD
Duloxetine—Vomiting—Hydrocortisone—rheumatoid arthritis	0.00024	0.000311	CcSEcCtD
Duloxetine—Rash—Hydrocortisone—rheumatoid arthritis	0.000238	0.000309	CcSEcCtD
Duloxetine—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000237	0.000308	CcSEcCtD
Duloxetine—Confusional state—Methotrexate—rheumatoid arthritis	0.000236	0.000307	CcSEcCtD
Duloxetine—Headache—Hydrocortisone—rheumatoid arthritis	0.000236	0.000307	CcSEcCtD
Duloxetine—Dizziness—Triamcinolone—rheumatoid arthritis	0.000235	0.000305	CcSEcCtD
Duloxetine—Anaphylactic shock—Methotrexate—rheumatoid arthritis	0.000234	0.000304	CcSEcCtD
Duloxetine—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000234	0.000304	CcSEcCtD
Duloxetine—Infection—Methotrexate—rheumatoid arthritis	0.000233	0.000302	CcSEcCtD
Duloxetine—Feeling abnormal—Prednisone—rheumatoid arthritis	0.000231	0.0003	CcSEcCtD
Duloxetine—Asthenia—Dexamethasone—rheumatoid arthritis	0.000231	0.0003	CcSEcCtD
Duloxetine—Asthenia—Betamethasone—rheumatoid arthritis	0.000231	0.0003	CcSEcCtD
Duloxetine—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.00023	0.000298	CcSEcCtD
Duloxetine—Thrombocytopenia—Methotrexate—rheumatoid arthritis	0.000229	0.000298	CcSEcCtD
Duloxetine—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.000229	0.000298	CcSEcCtD
Duloxetine—Nausea—Prednisolone—rheumatoid arthritis	0.000229	0.000298	CcSEcCtD
Duloxetine—Pruritus—Betamethasone—rheumatoid arthritis	0.000228	0.000296	CcSEcCtD
Duloxetine—Pruritus—Dexamethasone—rheumatoid arthritis	0.000228	0.000296	CcSEcCtD
Duloxetine—Skin disorder—Methotrexate—rheumatoid arthritis	0.000228	0.000296	CcSEcCtD
Duloxetine—Hyperhidrosis—Methotrexate—rheumatoid arthritis	0.000227	0.000294	CcSEcCtD
Duloxetine—Vomiting—Triamcinolone—rheumatoid arthritis	0.000226	0.000293	CcSEcCtD
Duloxetine—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000225	0.000292	CcSEcCtD
Duloxetine—Nausea—Hydrocortisone—rheumatoid arthritis	0.000224	0.000291	CcSEcCtD
Duloxetine—Rash—Triamcinolone—rheumatoid arthritis	0.000224	0.000291	CcSEcCtD
Duloxetine—Dermatitis—Triamcinolone—rheumatoid arthritis	0.000224	0.00029	CcSEcCtD
Duloxetine—Anorexia—Methotrexate—rheumatoid arthritis	0.000223	0.00029	CcSEcCtD
Duloxetine—Rash—Methylprednisolone—rheumatoid arthritis	0.000223	0.00029	CcSEcCtD
Duloxetine—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.000223	0.00029	CcSEcCtD
Duloxetine—Urticaria—Prednisone—rheumatoid arthritis	0.000223	0.000289	CcSEcCtD
Duloxetine—Headache—Triamcinolone—rheumatoid arthritis	0.000222	0.000289	CcSEcCtD
Duloxetine—Headache—Methylprednisolone—rheumatoid arthritis	0.000222	0.000288	CcSEcCtD
Duloxetine—Body temperature increased—Prednisone—rheumatoid arthritis	0.000222	0.000288	CcSEcCtD
Duloxetine—Abdominal pain—Prednisone—rheumatoid arthritis	0.000222	0.000288	CcSEcCtD
Duloxetine—Diarrhoea—Betamethasone—rheumatoid arthritis	0.00022	0.000286	CcSEcCtD
Duloxetine—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.00022	0.000286	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	0.000213	0.000277	CcSEcCtD
Duloxetine—Dizziness—Dexamethasone—rheumatoid arthritis	0.000213	0.000276	CcSEcCtD
Duloxetine—Dizziness—Betamethasone—rheumatoid arthritis	0.000213	0.000276	CcSEcCtD
Duloxetine—Insomnia—Methotrexate—rheumatoid arthritis	0.000212	0.000275	CcSEcCtD
Duloxetine—Nausea—Triamcinolone—rheumatoid arthritis	0.000211	0.000274	CcSEcCtD
Duloxetine—Paraesthesia—Methotrexate—rheumatoid arthritis	0.00021	0.000273	CcSEcCtD
Duloxetine—Nausea—Methylprednisolone—rheumatoid arthritis	0.00021	0.000273	CcSEcCtD
Duloxetine—Somnolence—Methotrexate—rheumatoid arthritis	0.000208	0.000271	CcSEcCtD
Duloxetine—Hypersensitivity—Prednisone—rheumatoid arthritis	0.000207	0.000268	CcSEcCtD
Duloxetine—Dyspepsia—Methotrexate—rheumatoid arthritis	0.000206	0.000268	CcSEcCtD
Duloxetine—Vomiting—Dexamethasone—rheumatoid arthritis	0.000205	0.000266	CcSEcCtD
Duloxetine—Vomiting—Betamethasone—rheumatoid arthritis	0.000205	0.000266	CcSEcCtD
Duloxetine—Decreased appetite—Methotrexate—rheumatoid arthritis	0.000204	0.000265	CcSEcCtD
Duloxetine—Rash—Dexamethasone—rheumatoid arthritis	0.000203	0.000264	CcSEcCtD
Duloxetine—Rash—Betamethasone—rheumatoid arthritis	0.000203	0.000264	CcSEcCtD
Duloxetine—Dermatitis—Dexamethasone—rheumatoid arthritis	0.000203	0.000263	CcSEcCtD
Duloxetine—Dermatitis—Betamethasone—rheumatoid arthritis	0.000203	0.000263	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.000202	0.000263	CcSEcCtD
Duloxetine—Fatigue—Methotrexate—rheumatoid arthritis	0.000202	0.000262	CcSEcCtD
Duloxetine—Headache—Dexamethasone—rheumatoid arthritis	0.000202	0.000262	CcSEcCtD
Duloxetine—Headache—Betamethasone—rheumatoid arthritis	0.000202	0.000262	CcSEcCtD
Duloxetine—Asthenia—Prednisone—rheumatoid arthritis	0.000201	0.000261	CcSEcCtD
Duloxetine—Pain—Methotrexate—rheumatoid arthritis	0.0002	0.00026	CcSEcCtD
Duloxetine—Pruritus—Prednisone—rheumatoid arthritis	0.000198	0.000258	CcSEcCtD
Duloxetine—Feeling abnormal—Methotrexate—rheumatoid arthritis	0.000193	0.000251	CcSEcCtD
Duloxetine—Diarrhoea—Prednisone—rheumatoid arthritis	0.000192	0.000249	CcSEcCtD
Duloxetine—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	0.000192	0.000249	CcSEcCtD
Duloxetine—Nausea—Dexamethasone—rheumatoid arthritis	0.000191	0.000248	CcSEcCtD
Duloxetine—Nausea—Betamethasone—rheumatoid arthritis	0.000191	0.000248	CcSEcCtD
Duloxetine—Urticaria—Methotrexate—rheumatoid arthritis	0.000186	0.000242	CcSEcCtD
Duloxetine—Dizziness—Prednisone—rheumatoid arthritis	0.000185	0.000241	CcSEcCtD
Duloxetine—Abdominal pain—Methotrexate—rheumatoid arthritis	0.000185	0.000241	CcSEcCtD
Duloxetine—Body temperature increased—Methotrexate—rheumatoid arthritis	0.000185	0.000241	CcSEcCtD
Duloxetine—Vomiting—Prednisone—rheumatoid arthritis	0.000178	0.000232	CcSEcCtD
Duloxetine—Rash—Prednisone—rheumatoid arthritis	0.000177	0.00023	CcSEcCtD
Duloxetine—Dermatitis—Prednisone—rheumatoid arthritis	0.000177	0.000229	CcSEcCtD
Duloxetine—Headache—Prednisone—rheumatoid arthritis	0.000176	0.000228	CcSEcCtD
Duloxetine—Hypersensitivity—Methotrexate—rheumatoid arthritis	0.000173	0.000224	CcSEcCtD
Duloxetine—Asthenia—Methotrexate—rheumatoid arthritis	0.000168	0.000218	CcSEcCtD
Duloxetine—Nausea—Prednisone—rheumatoid arthritis	0.000167	0.000216	CcSEcCtD
Duloxetine—Pruritus—Methotrexate—rheumatoid arthritis	0.000166	0.000215	CcSEcCtD
Duloxetine—Diarrhoea—Methotrexate—rheumatoid arthritis	0.00016	0.000208	CcSEcCtD
Duloxetine—Dizziness—Methotrexate—rheumatoid arthritis	0.000155	0.000201	CcSEcCtD
Duloxetine—Vomiting—Methotrexate—rheumatoid arthritis	0.000149	0.000193	CcSEcCtD
Duloxetine—Rash—Methotrexate—rheumatoid arthritis	0.000148	0.000192	CcSEcCtD
Duloxetine—Dermatitis—Methotrexate—rheumatoid arthritis	0.000148	0.000192	CcSEcCtD
Duloxetine—Headache—Methotrexate—rheumatoid arthritis	0.000147	0.000191	CcSEcCtD
Duloxetine—Nausea—Methotrexate—rheumatoid arthritis	0.000139	0.000181	CcSEcCtD
Duloxetine—HTR6—Signaling Pathways—CD28—rheumatoid arthritis	7.12e-05	0.000309	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—BDKRB2—rheumatoid arthritis	7.11e-05	0.000309	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CXCL12—rheumatoid arthritis	7.11e-05	0.000309	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ACAN—rheumatoid arthritis	7.09e-05	0.000308	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—IL2—rheumatoid arthritis	7.05e-05	0.000307	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—ADRBK1—rheumatoid arthritis	7.03e-05	0.000306	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—IL6—rheumatoid arthritis	7.02e-05	0.000305	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CXCL13—rheumatoid arthritis	6.93e-05	0.000302	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CXCL10—rheumatoid arthritis	6.92e-05	0.000301	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CCL5—rheumatoid arthritis	6.86e-05	0.000298	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL2RB—rheumatoid arthritis	6.85e-05	0.000298	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CSF2—rheumatoid arthritis	6.76e-05	0.000294	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—UBE2D1—rheumatoid arthritis	6.7e-05	0.000291	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—MMP9—rheumatoid arthritis	6.67e-05	0.00029	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—SLC25A12—rheumatoid arthritis	6.67e-05	0.00029	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—RASGRP1—rheumatoid arthritis	6.63e-05	0.000288	CbGpPWpGaD
Duloxetine—SLC6A3—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	6.63e-05	0.000288	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—C5—rheumatoid arthritis	6.62e-05	0.000288	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CXCL8—rheumatoid arthritis	6.61e-05	0.000288	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—NFKB1—rheumatoid arthritis	6.6e-05	0.000287	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—MMP3—rheumatoid arthritis	6.6e-05	0.000287	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—rheumatoid arthritis	6.59e-05	0.000286	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CXCL12—rheumatoid arthritis	6.57e-05	0.000286	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—BDKRB2—rheumatoid arthritis	6.57e-05	0.000286	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—POMC—rheumatoid arthritis	6.56e-05	0.000285	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—IL6ST—rheumatoid arthritis	6.51e-05	0.000283	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NFATC1—rheumatoid arthritis	6.51e-05	0.000283	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—ADRBK1—rheumatoid arthritis	6.5e-05	0.000282	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—MAPK8—rheumatoid arthritis	6.49e-05	0.000282	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—PRKCQ—rheumatoid arthritis	6.49e-05	0.000282	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—GC—rheumatoid arthritis	6.49e-05	0.000282	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PTGES—rheumatoid arthritis	6.49e-05	0.000282	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CXCL10—rheumatoid arthritis	6.29e-05	0.000273	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IRAK1—rheumatoid arthritis	6.24e-05	0.000271	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TLE3—rheumatoid arthritis	6.24e-05	0.000271	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCL5—rheumatoid arthritis	6.23e-05	0.000271	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PLD4—rheumatoid arthritis	6.22e-05	0.000271	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCR6—rheumatoid arthritis	6.22e-05	0.000271	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CCR5—rheumatoid arthritis	6.18e-05	0.000269	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CX3CR1—rheumatoid arthritis	6.18e-05	0.000269	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CSF2—rheumatoid arthritis	6.14e-05	0.000267	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—RASGRP1—rheumatoid arthritis	6.13e-05	0.000266	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—SYK—rheumatoid arthritis	6.11e-05	0.000266	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—IL2RA—rheumatoid arthritis	6.09e-05	0.000265	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NCF2—rheumatoid arthritis	6.05e-05	0.000263	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—C3—rheumatoid arthritis	6.04e-05	0.000263	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PLB1—rheumatoid arthritis	6.03e-05	0.000262	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ACAN—rheumatoid arthritis	6.01e-05	0.000261	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—PRKCQ—rheumatoid arthritis	5.99e-05	0.000261	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—VEGFA—rheumatoid arthritis	5.99e-05	0.000261	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CCL5—rheumatoid arthritis	5.96e-05	0.000259	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—POMC—rheumatoid arthritis	5.96e-05	0.000259	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL2RB—rheumatoid arthritis	5.95e-05	0.000259	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TRAF6—rheumatoid arthritis	5.9e-05	0.000256	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—SH2B3—rheumatoid arthritis	5.9e-05	0.000256	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—STAT1—rheumatoid arthritis	5.89e-05	0.000256	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CSF2—rheumatoid arthritis	5.87e-05	0.000255	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—GZMB—rheumatoid arthritis	5.86e-05	0.000255	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CCL2—rheumatoid arthritis	5.83e-05	0.000253	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—IL6R—rheumatoid arthritis	5.81e-05	0.000253	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CXCL10—rheumatoid arthritis	5.81e-05	0.000252	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—C5—rheumatoid arthritis	5.75e-05	0.00025	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CXCL8—rheumatoid arthritis	5.74e-05	0.00025	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—MMP3—rheumatoid arthritis	5.73e-05	0.000249	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—rheumatoid arthritis	5.72e-05	0.000249	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CXCL2—rheumatoid arthritis	5.69e-05	0.000247	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCL3—rheumatoid arthritis	5.69e-05	0.000247	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NFATC1—rheumatoid arthritis	5.65e-05	0.000246	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—SLC25A12—rheumatoid arthritis	5.65e-05	0.000246	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCR5—rheumatoid arthritis	5.61e-05	0.000244	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—SAA1—rheumatoid arthritis	5.56e-05	0.000242	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—IL2RA—rheumatoid arthritis	5.53e-05	0.000241	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—TGFB1—rheumatoid arthritis	5.5e-05	0.000239	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PTGES—rheumatoid arthritis	5.5e-05	0.000239	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—GC—rheumatoid arthritis	5.5e-05	0.000239	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—C3—rheumatoid arthritis	5.49e-05	0.000239	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NCF1—rheumatoid arthritis	5.45e-05	0.000237	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCL5—rheumatoid arthritis	5.41e-05	0.000235	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCR6—rheumatoid arthritis	5.4e-05	0.000235	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CCR5—rheumatoid arthritis	5.37e-05	0.000233	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CSF2—rheumatoid arthritis	5.33e-05	0.000232	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—MMP3—rheumatoid arthritis	5.3e-05	0.00023	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—TYK2—rheumatoid arthritis	5.29e-05	0.00023	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—IL2RA—rheumatoid arthritis	5.29e-05	0.00023	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—MED1—rheumatoid arthritis	5.29e-05	0.00023	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NCF2—rheumatoid arthritis	5.26e-05	0.000229	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—C3—rheumatoid arthritis	5.25e-05	0.000228	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CD28—rheumatoid arthritis	5.24e-05	0.000228	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—SH2B3—rheumatoid arthritis	5.12e-05	0.000223	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TRAF6—rheumatoid arthritis	5.12e-05	0.000223	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PLB1—rheumatoid arthritis	5.11e-05	0.000222	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—PTK2—rheumatoid arthritis	5.1e-05	0.000222	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—GZMB—rheumatoid arthritis	5.09e-05	0.000221	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CXCL8—rheumatoid arthritis	5.07e-05	0.000221	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCL5—rheumatoid arthritis	5e-05	0.000217	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CXCL2—rheumatoid arthritis	4.94e-05	0.000215	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCL3—rheumatoid arthritis	4.94e-05	0.000215	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—UBE2D1—rheumatoid arthritis	4.93e-05	0.000215	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CSF2—rheumatoid arthritis	4.92e-05	0.000214	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—B3GNT2—rheumatoid arthritis	4.92e-05	0.000214	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ACP5—rheumatoid arthritis	4.92e-05	0.000214	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCR5—rheumatoid arthritis	4.87e-05	0.000212	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—IL2—rheumatoid arthritis	4.85e-05	0.000211	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CXCL12—rheumatoid arthritis	4.84e-05	0.00021	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—BDKRB2—rheumatoid arthritis	4.84e-05	0.00021	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—SAA1—rheumatoid arthritis	4.83e-05	0.00021	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—POMC—rheumatoid arthritis	4.83e-05	0.00021	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—IL2RA—rheumatoid arthritis	4.8e-05	0.000209	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—IL6ST—rheumatoid arthritis	4.8e-05	0.000209	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—ADRBK1—rheumatoid arthritis	4.78e-05	0.000208	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—C3—rheumatoid arthritis	4.76e-05	0.000207	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NCF1—rheumatoid arthritis	4.73e-05	0.000206	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—SPP1—rheumatoid arthritis	4.63e-05	0.000201	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CXCL8—rheumatoid arthritis	4.61e-05	0.0002	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CD28—rheumatoid arthritis	4.55e-05	0.000198	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—TP53—rheumatoid arthritis	4.53e-05	0.000197	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—RASGRP1—rheumatoid arthritis	4.51e-05	0.000196	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCR5—rheumatoid arthritis	4.5e-05	0.000196	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—SYK—rheumatoid arthritis	4.5e-05	0.000196	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—MED1—rheumatoid arthritis	4.48e-05	0.000195	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IL2RA—rheumatoid arthritis	4.44e-05	0.000193	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—BGN—rheumatoid arthritis	4.43e-05	0.000192	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—PRKCQ—rheumatoid arthritis	4.41e-05	0.000192	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—IL2—rheumatoid arthritis	4.4e-05	0.000191	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—C3—rheumatoid arthritis	4.4e-05	0.000191	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—POMC—rheumatoid arthritis	4.39e-05	0.000191	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—STAT1—rheumatoid arthritis	4.34e-05	0.000189	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCL2—rheumatoid arthritis	4.29e-05	0.000187	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—UBE2D1—rheumatoid arthritis	4.28e-05	0.000186	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—IL6R—rheumatoid arthritis	4.28e-05	0.000186	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CXCL10—rheumatoid arthritis	4.28e-05	0.000186	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CXCL12—rheumatoid arthritis	4.2e-05	0.000183	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—BDKRB2—rheumatoid arthritis	4.2e-05	0.000183	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—POMC—rheumatoid arthritis	4.19e-05	0.000182	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—IL6ST—rheumatoid arthritis	4.17e-05	0.000181	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—B3GNT2—rheumatoid arthritis	4.16e-05	0.000181	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ACP5—rheumatoid arthritis	4.16e-05	0.000181	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—ADRBK1—rheumatoid arthritis	4.15e-05	0.000181	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—IL6—rheumatoid arthritis	4.15e-05	0.00018	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—LEP—rheumatoid arthritis	4.1e-05	0.000178	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ALOX5—rheumatoid arthritis	4.07e-05	0.000177	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—RASGRP1—rheumatoid arthritis	3.92e-05	0.00017	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—SYK—rheumatoid arthritis	3.91e-05	0.00017	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—MMP3—rheumatoid arthritis	3.9e-05	0.00017	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—TYK2—rheumatoid arthritis	3.9e-05	0.000169	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—FN1—rheumatoid arthritis	3.86e-05	0.000168	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IL6ST—rheumatoid arthritis	3.85e-05	0.000167	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PRKCQ—rheumatoid arthritis	3.83e-05	0.000167	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—POMC—rheumatoid arthritis	3.81e-05	0.000166	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—STAT1—rheumatoid arthritis	3.77e-05	0.000164	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—PTK2—rheumatoid arthritis	3.75e-05	0.000163	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—BGN—rheumatoid arthritis	3.75e-05	0.000163	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CXCL8—rheumatoid arthritis	3.74e-05	0.000162	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCL2—rheumatoid arthritis	3.73e-05	0.000162	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—IL6R—rheumatoid arthritis	3.72e-05	0.000162	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CXCL10—rheumatoid arthritis	3.71e-05	0.000161	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CD80—rheumatoid arthritis	3.7e-05	0.000161	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCL5—rheumatoid arthritis	3.68e-05	0.00016	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CSF2—rheumatoid arthritis	3.63e-05	0.000158	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—IL2—rheumatoid arthritis	3.57e-05	0.000155	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—POMC—rheumatoid arthritis	3.52e-05	0.000153	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ALOX5—rheumatoid arthritis	3.45e-05	0.00015	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCL2—rheumatoid arthritis	3.44e-05	0.00015	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IL6R—rheumatoid arthritis	3.43e-05	0.000149	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—SPP1—rheumatoid arthritis	3.41e-05	0.000148	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CXCL8—rheumatoid arthritis	3.39e-05	0.000148	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—MMP3—rheumatoid arthritis	3.39e-05	0.000147	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—TYK2—rheumatoid arthritis	3.38e-05	0.000147	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ENO1—rheumatoid arthritis	3.32e-05	0.000144	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCR5—rheumatoid arthritis	3.32e-05	0.000144	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL2RA—rheumatoid arthritis	3.27e-05	0.000142	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PTK2—rheumatoid arthritis	3.26e-05	0.000142	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	3.25e-05	0.000141	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—IL2—rheumatoid arthritis	3.24e-05	0.000141	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—C3—rheumatoid arthritis	3.24e-05	0.000141	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCL5—rheumatoid arthritis	3.2e-05	0.000139	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CSF2—rheumatoid arthritis	3.15e-05	0.000137	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—TYK2—rheumatoid arthritis	3.13e-05	0.000136	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—IL2—rheumatoid arthritis	3.1e-05	0.000135	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NOS3—rheumatoid arthritis	3.07e-05	0.000133	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	3.03e-05	0.000132	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—LEP—rheumatoid arthritis	3.02e-05	0.000131	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—SPP1—rheumatoid arthritis	2.96e-05	0.000129	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CXCL8—rheumatoid arthritis	2.95e-05	0.000128	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCR5—rheumatoid arthritis	2.88e-05	0.000125	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—FN1—rheumatoid arthritis	2.84e-05	0.000124	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL2RA—rheumatoid arthritis	2.84e-05	0.000123	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL6ST—rheumatoid arthritis	2.83e-05	0.000123	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—IL2—rheumatoid arthritis	2.82e-05	0.000122	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—C3—rheumatoid arthritis	2.81e-05	0.000122	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ENO1—rheumatoid arthritis	2.81e-05	0.000122	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.77e-05	0.00012	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CD80—rheumatoid arthritis	2.73e-05	0.000119	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CXCL8—rheumatoid arthritis	2.72e-05	0.000118	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—LEP—rheumatoid arthritis	2.62e-05	0.000114	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IL2—rheumatoid arthritis	2.6e-05	0.000113	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—POMC—rheumatoid arthritis	2.59e-05	0.000113	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—IL6—rheumatoid arthritis	2.59e-05	0.000113	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCL2—rheumatoid arthritis	2.54e-05	0.00011	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL6R—rheumatoid arthritis	2.53e-05	0.00011	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—FN1—rheumatoid arthritis	2.47e-05	0.000107	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—MMP9—rheumatoid arthritis	2.46e-05	0.000107	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL6ST—rheumatoid arthritis	2.46e-05	0.000107	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NFKB1—rheumatoid arthritis	2.44e-05	0.000106	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.42e-05	0.000105	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—MAPK8—rheumatoid arthritis	2.39e-05	0.000104	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CAT—rheumatoid arthritis	2.39e-05	0.000104	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CD80—rheumatoid arthritis	2.37e-05	0.000103	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TYK2—rheumatoid arthritis	2.3e-05	0.0001	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NOS3—rheumatoid arthritis	2.26e-05	9.83e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—POMC—rheumatoid arthritis	2.25e-05	9.79e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—VEGFA—rheumatoid arthritis	2.21e-05	9.61e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCL2—rheumatoid arthritis	2.2e-05	9.57e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL6R—rheumatoid arthritis	2.2e-05	9.55e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—TGFB1—rheumatoid arthritis	2.03e-05	8.82e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CAT—rheumatoid arthritis	2.02e-05	8.8e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CXCL8—rheumatoid arthritis	2e-05	8.72e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TYK2—rheumatoid arthritis	2e-05	8.69e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	1.99e-05	8.67e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NOS3—rheumatoid arthritis	1.96e-05	8.53e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL2—rheumatoid arthritis	1.92e-05	8.33e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—IL6—rheumatoid arthritis	1.91e-05	8.29e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—MMP9—rheumatoid arthritis	1.81e-05	7.88e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NFKB1—rheumatoid arthritis	1.79e-05	7.8e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—MAPK8—rheumatoid arthritis	1.76e-05	7.67e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CXCL8—rheumatoid arthritis	1.74e-05	7.57e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	1.69e-05	7.35e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—TP53—rheumatoid arthritis	1.67e-05	7.26e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL2—rheumatoid arthritis	1.66e-05	7.23e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—IL6—rheumatoid arthritis	1.66e-05	7.2e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—VEGFA—rheumatoid arthritis	1.63e-05	7.08e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—POMC—rheumatoid arthritis	1.6e-05	6.94e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—MMP9—rheumatoid arthritis	1.57e-05	6.85e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NFKB1—rheumatoid arthritis	1.56e-05	6.77e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—MAPK8—rheumatoid arthritis	1.53e-05	6.66e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IL6—rheumatoid arthritis	1.53e-05	6.65e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TGFB1—rheumatoid arthritis	1.49e-05	6.5e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ALB—rheumatoid arthritis	1.45e-05	6.32e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—VEGFA—rheumatoid arthritis	1.41e-05	6.15e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	1.39e-05	6.05e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—POMC—rheumatoid arthritis	1.35e-05	5.88e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TGFB1—rheumatoid arthritis	1.3e-05	5.64e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	1.27e-05	5.53e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ALB—rheumatoid arthritis	1.23e-05	5.36e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TP53—rheumatoid arthritis	1.23e-05	5.35e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	1.18e-05	5.13e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL6—rheumatoid arthritis	1.13e-05	4.9e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	1.08e-05	4.69e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TP53—rheumatoid arthritis	1.07e-05	4.65e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL6—rheumatoid arthritis	9.78e-06	4.25e-05	CbGpPWpGaD
